199 related articles for article (PubMed ID: 4401812)
1. Pharmacological effects of two new -adrenoceptor blocking drugs: Kö 1366 and Kö 1313.
Cheymol G; Honnorat C; Schmitt H
Eur J Pharmacol; 1972 Mar; 17(3):341-51. PubMed ID: 4401812
[No Abstract] [Full Text] [Related]
2. [Studies on cardiovascular drugs. VII. Adrenergic -receptor blocking activities of 1-tert-butylamino-3-(o-(tetrahydrofururyloxy)-phenoxy)-2-propanol hydrochloride (Y-6124)].
Nakanishi M; Imamura H; Nakamura T; Kimura T
Yakugaku Zasshi; 1972 Apr; 92(4):375-83. PubMed ID: 4403075
[No Abstract] [Full Text] [Related]
3. New N-isopropyl and N-tert.-butyl-phenoxypropanolaminic derivatives having -adrenolytic, anti-arrhythmic and local anaesthetic activity.
Marmo E; Caputi AP; Saini RK
Arzneimittelforschung; 1972 Jul; 22(7):1109-17. PubMed ID: 4404342
[No Abstract] [Full Text] [Related]
4. Effect of o-2-hydroxy-3-(tert.-butylamino) propoxybenzonitrile HCl (KO 1366) on beta adrenergic receptors in the cardiovascular system.
Nayler WG; Tay J
J Pharmacol Exp Ther; 1972 Feb; 180(2):302-16. PubMed ID: 4400889
[No Abstract] [Full Text] [Related]
5. Antisympathomimetic effects of Kö 1313 and Kö 1366 in guinea-pig atria.
Ban T
Jpn J Pharmacol; 1973 Apr; 23(2):251-8. PubMed ID: 4147484
[No Abstract] [Full Text] [Related]
6. Beta-adrenergic blocking activity and haemodynamic effects in man of Kö 1313, a new beta-adrenergic antagonist.
Gilfrich HJ; Rahn KH; Nicolescu RF
Eur J Clin Pharmacol; 1971 Sep; 3(4):204-8. PubMed ID: 4402827
[No Abstract] [Full Text] [Related]
7. [Pharmacological studies on the combination of a coronary dilator with a beta-receptor blocking agent].
Kadatz R; Diederen W
Arzneimittelforschung; 1972 Sep; 22(9):1449-54. PubMed ID: 4405011
[No Abstract] [Full Text] [Related]
8. Beta-receptor blocking and cardiodepressant actions of 2-nitrilophenoxypropanolamines.
Mylecharane EJ; Raper C
Eur J Pharmacol; 1971 Sep; 16(1):14-20. PubMed ID: 4400509
[No Abstract] [Full Text] [Related]
9. Studies of 1-(o-cyclopropylphenoxy)-3-isopropylamino-2-propanol, a new -adrenergic blocking drug.
Boissier JR; Giudicelli JF; Viars P; Advenier C; Mouille P; Larno S
Eur J Pharmacol; 1971 Jul; 15(2):151-9. PubMed ID: 4403548
[No Abstract] [Full Text] [Related]
10. [Pharmacological studies with 1-isopropylamino-3-(o-allyloxyphenoxy)-2-propanol-hydrochloride, an adrenergic beta-receptor blocking agent].
Brunner H; Hedwall PR; Meier M
Arzneimittelforschung; 1968 Feb; 18(2):164-70. PubMed ID: 5695373
[No Abstract] [Full Text] [Related]
11. [Circulatory effects of a new specific beta adrenergic blocking agent, (o-(2-hydroxy-3-(tert. butylamino)-propoxyl)-benzonitrile, Kö 1366)].
Gilfrich HJ; Rahn KH; Nicolescu RF
Arzneimittelforschung; 1973 Jun; 23(6):768-71. PubMed ID: 4146902
[No Abstract] [Full Text] [Related]
12. Coronary vasomotor responses to cardiac sympathetic nerve stimulation in the dog treated with beta adrenoceptor blocking agents.
Takenaka F; Ishihara T
Jpn J Pharmacol; 1972 Oct; 22(5):721-3. PubMed ID: 4405463
[No Abstract] [Full Text] [Related]
13. Electrophysiological evaluation of anesthetic actions of some beta-adrenergic blockers on guinea-pig cardiac muscles.
Washizu Y
Arch Int Pharmacodyn Ther; 1973 Apr; 202(2):263-9. PubMed ID: 4144372
[No Abstract] [Full Text] [Related]
14. Beta-adrenergic receptor blocking properties of three allyl-substituted phenoxypropanolamines.
Ablad B; Brogård M; Carlsson E; Ek L
Eur J Pharmacol; 1970; 13(1):59-64. PubMed ID: 4395676
[No Abstract] [Full Text] [Related]
15. Treadmill exercise in dogs under -adrenergic blockade: adaptation of coronary and systemic hemodynamics.
Bassenge E; Kucharczyk M; Holtz J; Stoian D
Pflugers Arch; 1972; 332(1):40-55. PubMed ID: 4401667
[No Abstract] [Full Text] [Related]
16. Pharmacological studies on 1-(7-indenyloxy)-3-isopropylaminopropan-2-Ol hydrochloride (YB-2), a new -adrenergic blocking agent.
Tachikawa S; Takenaka T
Arch Int Pharmacodyn Ther; 1973 Mar; 202(1):79-92. PubMed ID: 4144371
[No Abstract] [Full Text] [Related]
17. A new potentially antianginal benzofuran with an amiodarone-like pharmacological profile.
Charlier R; Bauthier J
Arzneimittelforschung; 1973 Sep; 23(9):1305-11. PubMed ID: 4801226
[No Abstract] [Full Text] [Related]
18. [Pharmacological study of a new adrenergic beta receptor blocking agent: 1-isopropylamino-3-(1,2,3,4-tetrahydro-1,4-ethano-5-naphthoxy)-2-propanol hydrochloride (K4423)].
Bergamaschi M; Mandelli V; Tommasini R; Turba C; Usardi MM
Boll Chim Farm; 1972 Nov; 111(11):667-87. PubMed ID: 4144099
[No Abstract] [Full Text] [Related]
19. The assessment of -adrenoceptor blocking potency and cardioselectivity in vitro and in vivo.
Baird JR; Linnell J
J Pharm Pharmacol; 1972 Nov; 24(11):880-5. PubMed ID: 4405651
[No Abstract] [Full Text] [Related]
20. Pharmacological actions of 1-(o-methoxyphenoxy)3-isopropylamino-2-propanol hydrochloride (S-D-1601), a new beta-blocking agent.
Ferrini R; Miragoli G; Croce G
Arzneimittelforschung; 1970 Aug; 20(8):1074-9. PubMed ID: 4394830
[No Abstract] [Full Text] [Related]
[Next] [New Search]
